DUBLIN–(BUSINESS WIRE)–The “Global Prostate Cancer Diagnostics Market (2022-2027) by Test Type, Age Group, End User, and Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis” report has been added to ResearchAndMarkets.com’s offering.
The Global Prostate Cancer Diagnostics Market is estimated to be USD 1.16 Bn in 2022 and expected to reach USD 2.27 Bn by 2027, growing at a CAGR of 14.33%.
Market Dynamics
Drivers
- Rising Aging Population and Increasing Prevalence Rate of Prostate Cancer
- Growing Government’s Initiatives for Advancement in Technology in Diagnosis and Creating Awareness Regarding Cancer
Restraints
- Stringent Regulations and High Cost of Diagnosis
Opportunities
- Innovation in Drugs and Developments in Genomics and Proteomics
- Imaging Research and Advancements for Accurate Detection of Prostate Cancer
Challenges
- Low Success Rate of Clinical Trials
Market Segmentations
The Global Prostate Cancer Diagnostics Market is segmented based on Test Type, Age Group, End User, and Geography.
- By Test Type, the market is classified into Confirmatory Tests and Preliminary Tests.
- By Age Group, the market is classified into Age 55-75, Age < 55, and Age>75.
- By End User, the market is classified into Cancer Research Institutes, Hospital Associated Laboratories, and Independent Diagnostic Laboratories.
- By Geography, the market is classified into Americas, Europe, Middle-East & Africa, and Asia-Pacific.
Competitive Quadrant
The report includes a Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.
Ansoff Analysis
The report presents a detailed Ansoff matrix analysis for the Global Prostate Cancer Diagnostics Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.
The analyst analyses the Global Prostate Cancer Diagnostics Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.
Based on the SWOT analysis conducted on the industry and industry players, the analyst has devised suitable strategies for market growth.
Why buy this report?
- The report offers a comprehensive evaluation of the Global Prostate Cancer Diagnostics Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
- The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
- The report includes an in-depth market analysis using Porter’s 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report.
- The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
- The report also contains the competitive analysis using Positioning Quadrants, the analyst’s competitive positioning tool.
Key Topics Covered:
1 Report Description
2 Research Methodology
3 Executive Summary
4 Market Dynamics
5 Market Analysis
6 Global Prostate Cancer Diagnostics Market, By Test Type
7 Global Prostate Cancer Diagnostics Market, By Age Group
8 Global Prostate Cancer Diagnostics Market, By End User
9 Americas’ Prostate Cancer Diagnostics Market
10 Europe’s Prostate Cancer Diagnostics Market
11 Middle East and Africa’s Prostate Cancer Diagnostics Market
12 APAC’s Prostate Cancer Diagnostics Market
13 Competitive Landscape
14 Company Profiles
15 Appendix
Companies Mentioned
- Abbott Laboratories
- Abbvie Inc.
- Accuquik Test Kits (AdvaCare Pharma USA)
- Astellas Pharma Inc.
- Beckman Coulter, Inc.
- bioMerieux, Inc.
- Dendreon Pharmaceuticals LLC
- DiaSorin S.p.A.
- Eurolyser Diagnostica GmbH
- Exact Sciences Corp.
- Fujirebio (H.U. Group company)
- Humasis Co. Ltd.
- Koninklijke Philips N.V.
- Life Length S.L
- Metamark Genetics, Inc.
- Myriad Genetics, Inc
- OPKO Health, Inc.
- Prostatype Genomics AB
- Proteomedix Ag
- Roche Diagnostics Ag
- Siemens Healthineers Ag
- Tolmar Inc.
For more information about this report visit https://www.researchandmarkets.com/r/hy7gp2
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900